Cargando…

Prediction of Survival Rate and Chemotherapy Effect by an Immune Score Model in Colorectal Cancer

Colorectal cancer is the third most common cancer and the second leading cause of cancer-related deaths. Immune cells in the tumor microenvironment play an important role in the development of tumors. In this study, CIBERSORT was used to estimate the subset of the immune cells using bulk gene expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Siyao, Wang, Zhengjian, Ntim, Michael, Han, Jingrun, Jiang, Xutao, Fang, Chuanfa, Xu, Caiming, Zhang, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006078/ https://www.ncbi.nlm.nih.gov/pubmed/35434132 http://dx.doi.org/10.1155/2022/8219701

Ejemplares similares

An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer
por: Sui, Silei, et al.
Publicado: (2020)

Low ferroptosis score predicts chemotherapy responsiveness and immune‐activation in colorectal cancer
por: Lv, Yang, et al.
Publicado: (2022)

Survival prediction in patients with resectable colorectal liver metastases: Clinical risk scores and tumor response to chemotherapy
por: Xu, Da, et al.
Publicado: (2017)

Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy
por: Zhao, Jie, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy Followed by Radiofrequency Ablation Prolongs Survival for Ablatable Colorectal Liver Metastasis: A Propensity Score Matching Comparative Study
por: Chen, Yizhen, et al.
Publicado: (2021)

Impact of Neoadjuvant Chemotherapy on Clinical Risk Scores and Survival in Patients with Colorectal Liver Metastases
por: Wimmer, Kerstin, et al.
Publicado: (2016)

Prediction of Prognosis, Immunotherapy and Chemotherapy with an Immune-Related Risk Score Model for Endometrial Cancer
por: Wei, Wei, et al.
Publicado: (2023)

The landscape of immune cell infiltration and its clinical implications of pancreatic ductal adenocarcinoma
por: Xu, Caiming, et al.
Publicado: (2020)

Neurotransmitters: promising immune modulators in the tumor microenvironment
por: Xiao, Luxi, et al.
Publicado: (2023)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

Metastasis immune-based scores predict patient survival
por: Mlecnik, Bernhard, et al.
Publicado: (2020)

lncRNA Expression-Based Risk Scoring System Can Predict Survival of Tumor-Positive Patients with Hepatocellular Carcinoma
por: Wu, Siyao, et al.
Publicado: (2021)

Retracted: Ovarian Cancer Risk Scores Based on Immune-Related Pseudogenes to Predict Overall Survival and Guide Immunotherapy and Chemotherapy
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Mitophagy-related gene signature predicts prognosis, immune infiltration and chemotherapy sensitivity in colorectal cancer
por: Weng, Jin-Sen, et al.
Publicado: (2023)

Development and Validation of an Autophagy Score Signature for the Prediction of Post-operative Survival in Colorectal Cancer
por: Zhou, Zheng, et al.
Publicado: (2019)

Risk scoring based on expression of long non-coding RNAs can effectively predict survival in hepatocellular carcinoma patients with or without fibrosis
por: Ye, Jiaxiang, et al.
Publicado: (2020)

Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score (mCCS)
por: Marschner, N., et al.
Publicado: (2019)

Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy
por: Catalano, V, et al.
Publicado: (2009)

Lactate score predicts survival, immune cell infiltration and response to immunotherapy in breast cancer
por: Yin, Ting-Ting, et al.
Publicado: (2022)

CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer
por: Sun, Kai-Yu, et al.
Publicado: (2020)

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score
por: Draeger, Desiree-Louise, et al.
Publicado: (2023)

GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy
por: Wang, Zaozao, et al.
Publicado: (2014)

Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma
por: Yang, Xiaodong, et al.
Publicado: (2019)

Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
por: Wilkinson, Kate, et al.
Publicado: (2021)

Establishment of an Immune Cell Infiltration Score to Help Predict the Prognosis and Chemotherapy Responsiveness of Gastric Cancer Patients
por: Jiang, Quan, et al.
Publicado: (2021)

A retrospective cohort study of clinical value of PRL-3 in stage III human colorectal cancer
por: Liu, Chuanyuan, et al.
Publicado: (2021)

Species-Level Analysis of the Human Gut Microbiome Shows Antibiotic Resistance Genes Associated With Colorectal Cancer
por: Liu, Chuanfa, et al.
Publicado: (2021)

Prolonged survival in metastatic colorectal cancer following chemotherapy
por: Paul, Doru, et al.
Publicado: (2014)

A cancer-associated fibroblast gene signature predicts prognosis and therapy response in patients with pancreatic cancer
por: Zhang, Jinbao, et al.
Publicado: (2022)

A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
por: Qian, Jing, et al.
Publicado: (2016)

TYMS/KRAS/BRAF molecular profiling predicts survival following adjuvant chemotherapy in colorectal cancer
por: Ntavatzikos, Anastasios, et al.
Publicado: (2019)

Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
por: Turkington, Richard C, et al.
Publicado: (2019)

Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer
por: Xia, Siyu, et al.
Publicado: (2021)

Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores—— A retrospective, propensity score matching analysis
por: Chen, Feng-Lin, et al.
Publicado: (2022)

Immune infiltration and immune gene signature predict the response to fluoropyrimidine-based chemotherapy in colorectal cancer patients
por: Mo, Xianwei, et al.
Publicado: (2020)

Major Pathologic Response and Prognostic Score Predict Survival in Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy
por: Pataer, Apar, et al.
Publicado: (2022)

Composite Score: prognostic tool to predict survival in patients undergoing surgery for colorectal liver metastases
por: Frühling, Petter, et al.
Publicado: (2021)

A Novel Immune Gene-Related Prognostic Score Predicts Survival and Immunotherapy Response in Glioma
por: Luo, Xuehui, et al.
Publicado: (2022)

Construction and Validation of an Immune-Related Risk Score Model for Survival Prediction in Glioblastoma
por: Ren, Wei, et al.
Publicado: (2022)

Recurrence and survival rates of inflammatory bowel disease-associated colorectal cancer following postoperative chemotherapy: a comparative study
por: Dugum, Mohannad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_gf9d76lrvpqf0876fcrmdtbu0f